PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Precision Anatomical Pathology for Cancer Cell Growth & Preservation Diagnostic Testing Patient Record & Billing Solutions Diabetes Management Technology Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PHC Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Corporation (Shanghai) Ltd.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PHC Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Corporation (Shanghai) Ltd.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2026 > Announcement of Clarification of Business Unit Names

News


2026

AnnouncementMarch 30, 2026

Announcement of Clarification of Business Unit Names

As part of our commitment to stakeholder engagement, PHC Group is always seeking to help our stakeholders better understand our global business and its parts. To support this goal, we will update how we refer to two of our business units, effective April 1:

Domain Current Business Unit Name New Business Unit Name
Diabetes Management BGM Business Unit Diabetes Management Business Unit
Healthcare Solutions LSIM Business Unit Clinical Testing Business Unit

The purpose of this update is to make our business activities easier to understand by using clearer names that describe what each unit does. The brand names of the relevant businesses (Ascensia and LSI Medience) will not change.

As a reminder, we will also implement a business unit reorganization within the Diagnostics & Life Sciences Domain effective April 1.
https://www.phchd.com/global/news/2026/0225

PHC Group remains committed to delivering innovative, high-quality precision technology to support the health of society.

PHCbi will continue as a product brand.

Media contact

PHC Holdings Corporation
Corporate Communications Group
+81-3-6778-5311 E-mail:phc-pr@gg.phchd.com

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.